Portfolio Choice  123    15   

Published: Feb 15, 2022
Updated: Feb 15, 2022

AMRUTANJAN HEALTH CARE
BSE ticker code 590006
NSE ticker code AMRUTANJAN
Major activity Pharmaceuticals
Managing Director Sambhu Prasad Sivalenka
Equity capital Rs. 2.92 crore; FV Re. 01
52 week high/low Rs. 1026 / Rs. 472
CMP Rs. 832.85
Market Capitalisation Rs. 2523.54 crore
Recommendation Accumulate at declines
Going beyond its legendary balm

mrutanajan Health Care is an Indian pharmaceutical company engaged in the manufacture of ayurvedic health care products and beauty products. The company has diversified into information technology and the food business. Amrutanjan Infotech is engaged in IT services and business process outsourcing. Through acquisition of Siva’s Soft Drink Pvt Ltd, a Chennai-based company, it also started manufacturing fruit juices under the brand name ‘Fruitnick’. The company is internationally known for its Amrutanjan balm. It is growing slowly but steadily on the financial front and its prospects ahead are quite healthy for investors.

Consider:

  • The company, mainly known for its balm – a headache pain remover – for the last 100 years is a household name for this product.
  • The company is growing but very slowly. During the last five years its sales turnover has steadily increased from Rs. 219.63 crore in the fiscal 2017 to Rs. 332.84 crore in the fiscal 2021 with the operating profit moving up from Rs. 29.44 crore to Rs. 74.75 crore and the profit at net level inching up from Rs. 22.35 crore to Rs. 61.19 crore respectively during this five year period. The company's balance sheet is very healthy with strong financial position, its reserves at the end of March 31, 2021 standing at Rs. 212.64 crore - over 71 times its tiny equity capital of Rs. 2.92 crore. This is virtually a debt-free company with its interest during the fiscal 2021 being a fractional Rs. 50 lakh with rising demand for Ayurvedic medicines, the company's margins are on the rise.
  • With a view to achieving 113 per cent of its national sales through the e-commerce route, Amrutanjan has started investing in digitzation in a big way, building on the sales force automation project that was rolled out earlier by building a dashboard that seamlessly integrates data flow from various sources. Part of the digitization is also to offer its products for sale on its corporate website. Today, its products are available online on Amazon, Pharmeasy, Netmeds and Apollo. At present, the company has recorded sales of around Rs 1.92 crore through this route and the management wants to raise it to around Rs 5 crore in the first instance. Initially, the company would like to focus on growing the pain balm, health beverages and woman’s hygiene portfolio through this e-commerce route. The company is also working on a mobile application on its popular Comfi brand of sanitary napkins and related products, aimed at serving women in tracking menstrual and feminine health.
  • Amrutanjan has planned an aggressive marketing strategy. Accordingly, now it focuses on building distribution for its brands with the ‘M5K’ plan that targets a vision of appointing 5,000 distributors and subdistributors. Over a year ago, the company had appointed around 1,000 distributors and sub-distributors, improving direct coverage from 3,950 to 4,500 towns. Now, it would like to grow its distribution of its products to regions in the western and northern zones where its business is relatively weak.
  • In the meanwhile, the company has extended its product range instead of depending only on its pain balm. It launched an innovative back pain ‘Rollon’ format which became a runaway success. What is more. its competitors were forced to copy it. Again, Amrutanjan was the first company to introduce a Rs 2 sachet which was later copied by Zandu, its major competitor. The company also increased the efficacy of its products by augmenting the menthol content and launched a new cardboard packaging. All these changes have injected new life into the 125-year-old company.
  • The company has also entered the female hygiene category through its Comfy brand of sanitary pads, which is positioned as an affordable brand and targets users from semiurban and rural India. This is considered a category worth Rs 1,800-2,000 crore and major players Stayfree and Whisper enjoy a big share of this market. Amrutanjan has tremendous scope for promoting its product in the semiurban and village segments of th

Shares of the company are quoted around Rs 825. We feel this is quite an attractive bet. Investors with a long perspective will be able to reap rich harvest by investing in this company.

PERFORMANCE INDICATORS (Rs. in crore)

Year Net Sales Net Profit EPS (Rs.) Div (%) BV (%) RONW (%)
2018-19 253.20 24.50 8.40 215.0 51.10 17.90
2019-20 261.50 154.40 8.60 210.0 54.50 16.40
2020-21 332.84 61.12 20.90 420.0 81.80 32.60
ADVANCED ENZYME TECHNOLOGIES
BSE ticker code 540025
NSE ticker code ADVENZYMES
Major activity Agricultural Products
Chairman Vasant Rathi
Equity capital Rs. 22.36 crore; FV Rs. 02
52 week high/low Rs. 503 / Rs. 297
CMP Rs. 348.00
Market Capitalisation Rs. 3890.34 crore
Recommendation Buy at declines
Growing global enzyme footprint

Advanced Enzyme Technologies may be a small cap but it’s the largest enzyme manufacturing company in India. During the last two decades, it has transformed itself into a global enzyme powerhouse based on its R&D and tech innovation. It manufactures 400-plus proprietary products developed from over 68 indigenous enzymes and products. The company is one of the few manufacturers in the world to possess great depth and expertise in fermented manufacturing. AET has excellent growth prospects going ahead.

Consider:

  • The company caters to diversified industries and verticals like human nutrition, animal nutrition and bio-processing. It provides its proprietary enzyme products and customized enzyme products to various pharmaceutical and nutraceutical companies in India, other Asian countries, North America and Europe. The company has state-of-the-art manufacturing facilities and R&D centres across India, the US and Germany
  • AET has expanded its operations through the acquisition route. It acquired several companies, including CalIndia Foods International (which gave AET a direct presence in the US), Advanced Supplementary Technologies Corporation (which consolidated its presence in the US), JC Biotech Pvt Ltd, AEM of Malaysia and Evoxx Technologies GmbH. Today, the company has three wholly owned subsidiaries, three joint ventures and five step-down subsidiaries, all of which help AET service 700 clients spread across 45 countries.
  • With these acquisitions, the company has made slow but steady progress on the financial front. During the last 11 years, its sales turnover has advanced from Rs 116 crore in fiscal 2011 to Rs 502 crore in fiscal 2021, with the operating profit growing from Rs 23 crore to Rs 232 crore and the net profit inching up from Rs 17 crore to Rs 146 crore during this period. The company’s financial position is very strong, with reserves at the end of March 2021 standing at Rs 948 crore – more than 43 times its equity capital of Rs 22 crore. As its debt is negligible (Rs 23 crore), it is virtually a debt-free company.

GLOBAL POTENTIAL

From 2022 to 2028, the global technical enzymes market is expected to develop at a fast pace, according to the latest MarketsandResearch.biz document. For the forecast period, the paper proposes a marketshare estimation in terms of volumes. This study looks at the market definition, classifications, applications, engagements and global technical enzymes enterprise trends.

The local evaluation phase reveals the substantial capability of every region in the global technical enzymes marketplace collectively with its period and amount. The study explains expansion techniques and procedures, estimates, production processes and fee structures. It also consists of product offerings, revenue evaluation, production capabilities, gross margins and numerous different crucial elements that effect the profitability of the company involved in the market. Advanced Enzymes Technologies will be one of the major beneficiaries of this market potential.

  • Prospects ahead are highly promising as enzymes are used in a wide variety of industries like human healthcare and nutrition, animal nutrition, banking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, speciality applications and textile processing. The management expects sales to cross the Rs 1,000-crore mark within the next five years, with a corresponding improvement in earnings.
  • The company’s shareholding is in strong hands, with the promoters holding 52.55 per cent, foreign institutional investors (FIIs) 16.27 per cent and domestic institutional investors (DIIs) 8.67 per cent.

CONSOLIDATED PERFORMANCE INDICATORS (Rs. in crore)

Year Net Sales Net Profit EPS (Rs.) Div (%) BV (%) RONW (%)
2018-19 419.60 111.20 10.00 30.0 66.60 18.00
2019-20 444.00 129.30 11.60 30.0 75.20 17.00
2020-21 501.84 145.69 13.00 45.0 91.70 16.10
ADC INDIA COMMUNICATIONS
BSE ticker code 522074
NSE ticker code ELGIEQUIP
Major activity Industrial Machinery
Managing Director Jairam Varadaraj
Equity capital Rs. 31.69 crore; FV Re. 01
52 week high/low Rs. 423 / Rs. 173
CMP Rs. 306.50
Market Capitalisation Rs. 9713.26 crore
Recommendation Buy at declines
Financials poor, potential high

Headquartered in Bengaluru, ADC India Communications (formerly known as Krone Communications) is a leading player in broadband connectivity and provides connection solutions for wireline, wireless, cable broadcast and enterprise networks. The company is an undisputed leader in providing network infrastructure products and services that support its customers in migration to next generation networks. It plays a crucial role in enabling customers to deliver dynamic video, data, voice and wireless services that are increasingly essential to telcos, enterprises and infrastructure providers. Despite its important role, ADC’s shares are quoted at below intrinsic value and hence are worth buying.

Consider:

  • The telecom sector continues to be at the epicentre for growth, innovation and disruption for virtually any industry. According to a study, smartphones today account for two out of every three mobile connections globally. Mobile devices and related broadband connectivity continue to be more and more embedded in our daily life and are key in driving the momentum around key trends like video streaming, Internet of Things (IoT) and mobile payments. This trend is a key growth driver for ADC India Communications.
  • The company expects higher growth in the medium term driven by demand from infrastructure projects, the defence sector, e-commerce, hospitality, education, IT/ITeS and government projects. The company expects growth in the fiber business vis-à-vis copper due to the large infrastructure corridors, the national fiber optic network, and the ‘Digital India’ and ‘Smart City’ initiatives.
  • ADC has introduced new products like a fiber and copper patch lock system, which helps customers look at an additional level of physical security in critical connectivity requirements, and also continues its work in supporting highdensity fiber requirements for co-locations with better manageability feature
  • Communications service providers across the globe are continuing their rapid migration to next-generation networks that can deliver reliable broadband services over any device anytime, anywhere. At the same time, high speed enterprise networks and data centres continue to be built to meet the challenge of transmitting and storing the vast amounts of information critical for success in modern business. The need for ubiquitous access, scalable bandwidth and robust, reliable connectivity is no different for a carrier, cable company or enterprise. All depend on ADC's network infrastructure expertise to help them design and deploy high-speed wired networks offering dynamic video, data, and voice to businesses and consumers.
  • The company has also introduced new products that would cater to the telecom market such as fiber-to-antenna and copper-to-antenna products that will help support upcoming 4G projects. It has also introduced outdoor environment enclosures/cable assembly products to support the security and surveillance market and continues its focus on a standard-compliant product portfolio to increase its geographical reach
  • The company’s financial performance so far is not that heart-warming. During the last five years, its sales have declined marginally from Rs 62.32 crore in fiscal 2017 to Rs 126.60 crore in fiscal 2021, with the operating profit inching up fractionally from Rs 3.63 crore to Rs 4.84 crore and the net profit declining from Rs 3.82 crore to Rs 3.62 crore during this period. A plus point for the company is that it is a debtfree entity and is regular in payment of dividends, the rate for the last year being 25 per cent.

According to research analysts, at the current price of Rs. 380, the scrip is undervalued on the basis of its intrinsic value, which is Rs 522 as determined by the median of 3 historical modes.

PERFORMANCE INDICATORS (Rs. in crore)

Year Net Series Net Profit EPS (Rs.) Div (%) BV (%) RONW (%)
2018-19 85.62 5.86 12.70 ---- 110.00 7.82
2019-20 78.13 3.80 8.30 20.0 87.30 9.63
2020-21 59.86 3.61 7.80 25.0 98.80 8.69

Popular Stories

E-Waste Dilemma Tackling E-Waste Via Reverse Logistics, By Vihaan Shah

A modern-day enigma and a ramification of humanity's never-ending advancements, e-waste refers to the scum con- cealed by the outward glow of ever-advancing technology.

Archives

About Us    Contact Us    Careers    Terms & Condition    Privacy Policy

Liability clause: The investment recommendations made here are based on the personal judgement of the authors concerned. We do not accept liability for any losses that might occur. All rights reserved. Reproduction in any manner, in whole or in part, in English or in any other language is prohibited.

Copyright © 1983-2025 Corporate India. All Rights Reserved.

www.corporateind.com | Cookie Policy | Disclaimer